08 PA
Pill imprint 08 PA has been identified as Hydroxyzine hydrochloride 25 mg.
Hydroxyzine is used in the treatment of pain; anxiety; nausea/vomiting; sedation; allergies (and more), and belongs to the drug classes antihistamines, miscellaneous anxiolytics, sedatives and hypnotics. FDA has not classified the drug for risk during pregnancy.
Hydroxyzine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydroxyzine hydrochloride Images
- Imprint:
-
08
PA - Strength:
- 25 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
carnauba wax
silicon dioxide
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium starch glycolate type A potato
titanium dioxide
triacetin
- Drug Class:
- Antihistamines
Miscellaneous anxiolytics, sedatives and hypnotics - Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Pliva Inc.
- National Drug Code (NDC):
- 50111-0308
More HydrOXYzine Hydrochloride resources
- Hydroxyzine
- Hydroxyzine (Wolters Kluwer)
- Hydroxyzine Capsules (Wolters Kluwer)
- Hydroxyzine Suspension (Wolters Kluwer)
- Hydroxyzine Syrup (Wolters Kluwer)
- Rezine (Cerner Multum)
- hydroxyzine (Cerner Multum)
- Hydroxyzine Hydrochloride (AHFS DI)
- Hydroxyzine Pamoate (AHFS DI)
- Hydroxyzine (FDA)
- Hydroxyzine Capsules (FDA)
- Hydroxyzine Injection (FDA)
- Hydroxyzine Oral Solution (FDA)
- Hydroxyzine Pamoate (FDA)
- Hydroxyzine Syrup (FDA)
- Hydroxyzine Tablets (FDA)
- Hydroxyzine (Wolters Kluwer)


